Cargando…
Study on the protective mechanism of dexmedetomidine on the liver of perioperative diabetic patients: A randomized controlled trial
Although several studies have reported that dexmedetomidine is a highly selective α2-adrenergic receptor agonist that protects liver function in perioperative patients by inhibiting oxidative stress (OS) and inflammatory response, patients with type 2 diabetes mellitus (T2DM) have not been included...
Autores principales: | Zeng, Lin, Liu, Juan, Zhang, Tianyao, Liu, Yusong, Liao, Lumiu, Chen, Xuelian, Dong, Shuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575753/ https://www.ncbi.nlm.nih.gov/pubmed/36254014 http://dx.doi.org/10.1097/MD.0000000000030899 |
Ejemplares similares
-
The study of different dosages of remazolam combined with sufentanil and propofol on painless gastroscopy: A randomized controlled trial
por: Wu, Xiaohong, et al.
Publicado: (2023) -
Perioperative dexmedetomidine reduces emergence agitation without increasing the oculocardiac reflex in children: A systematic review and meta-analysis
por: Song, Jingyao, et al.
Publicado: (2021) -
Comparison of the effects of dexmedetomidine and remifentanil on perioperative hemodynamics and recovery profile of patients undergoing laryngeal microsurgery: A prospective randomized double-blinded study
por: Kim, Young Sung, et al.
Publicado: (2021) -
Neurocognitive Dysfunction Risk Alleviation With the Use of Dexmedetomidine in Perioperative Conditions or as ICU Sedation: A Meta-Analysis
por: Li, Bo, et al.
Publicado: (2015) -
Dexmedetomidine in Postoperative Analgesia in Patients Undergoing Hysterectomy: A CONSORT-Prospective, Randomized, Controlled Trial
por: Ren, Chunguang, et al.
Publicado: (2015)